Fox Chase Cancer Center News

PHILADELPHIA (November 21, 2024) — Jeffrey M. Farma, MD, FACS, Chair of the Department of Surgery at Fox Chase Cancer Center, recently received a Pennsylvania Impact Award.

PHILADELPHIA (November 20, 2024) — Lu Chen, PhD, an Assistant Professor in the Nuclear Dynamics and Cancer Research Program and member of the Cancer Epigenetics Institute at Fox Chase Cancer Center, has received a $250,000 grant to further investigate the role of RNA and the formation of liquid droplet structures within cancer cells.

PHILADELPHIA (November 19, 2024) — A team of lung cancer specialists from Fox Chase Cancer Center and Temple Health was recently recognized by the International Association for the Study of Lung Cancer (IASLC) as the winners of the North American Cancer Care Team Award (CCTA) during this year’s annual meeting in San Diego.

PHILADELPHIA (November 19, 2024) — A study led by a researcher at Fox Chase Cancer Center provides new insights into the cellular composition and microenvironment — the noncancerous cells and molecules surrounding tumor cells — of small cell lung cancer. The research team also identified two cellular signaling pathways that play a significant role in the cancer’s aggressiveness.

PHILADELPHIA (November 14, 2024) — Richard J. Bleicher, MD, FACS, Chief of the Division of Breast Surgery and Clinical Director of the Breast Service Line at Fox Chase Cancer Center, has been appointed Vice Chair of the National Accreditation Program for Breast Centers (NAPBC) and Chair of its Executive Committee.

PHILADELPHIA (November 14, 2024) — In patients with Lynch syndrome, the use of aspirin as a form of chemoprevention is lower than anticipated, according to a new study by researchers at Fox Chase Cancer Center to be presented at the 2024 meeting of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC).

PHILADELPHIA (November 13, 2024) — The gut microbiome — the collection of microbes that live in the intestines — is increasingly recognized to be involved in the development of disease, progression, and response to treatment, but to date only a few studies have investigated its role in bladder cancer.

PHILADELPHIA (November 12, 2024) — For patients with cancer in the lower part of the rectum that has not spread to the lymph nodes, chemotherapy administered before localized surgery is an effective method of preserving a patient’s surrounding organs, according to a new study by researchers at Fox Chase Cancer Center.